1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hunter, H.N.
Fulton, D.B.
Ganz, T.
Vogel, H.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
277
37597
37603
10.1074/jbc.M205305200
12138110
The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.
2002
10.2210/pdb1m4e/pdb
pdb_00001m4e
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
2203.828
Hepcidin
Hepcidin-20 (residues 65-84)
1
syn
polymer
Liver-expressed antimicrobial peptide, LEAP-1, Putative liver tumor regressor, PLTR, Hepc20
no
no
ICIFCCGCCHRSKCGMCCKT
ICIFCCGCCHRSKCGMCCKT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-11-06
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
The solution structure of hepcidin-25
RCSB
Y
RCSB
2002-07-02
REL
REL
The sequence of the protein is naturally found in Homo sapiens. The protein was chemically synthesized.
sample
This structure was determined using standard 2D homonuclear techniques.
structures with the lowest energy
100
20
2D NOESY
2D TOCSY
13C-HSQC
Diffusion
3.2
ambient
298
K
the structures are based on 285 NOE-derived distance constraints,
17 dihedral angle restraints, 5 distance restraints
from hydrogen bonds.
simulated annealing, molecular dynamics, matrix relaxation, torsion angle dynamics
1
lowest energy
0.78mM hepcidin-20
90% H2O/10% D2O
Bruker
collection
XwinNMR
2.6
Brunger et al
structure solution
CNS
1.1
Delaglio, F.
processing
NMRPipe
3.4
Brunger et al
refinement
CNS
1.1
500
Bruker
AVANCE
700
Bruker
AVANCE
ILE
1
n
1
ILE
1
A
CYS
2
n
2
CYS
2
A
ILE
3
n
3
ILE
3
A
PHE
4
n
4
PHE
4
A
CYS
5
n
5
CYS
5
A
CYS
6
n
6
CYS
6
A
GLY
7
n
7
GLY
7
A
CYS
8
n
8
CYS
8
A
CYS
9
n
9
CYS
9
A
HIS
10
n
10
HIS
10
A
ARG
11
n
11
ARG
11
A
SER
12
n
12
SER
12
A
LYS
13
n
13
LYS
13
A
CYS
14
n
14
CYS
14
A
GLY
15
n
15
GLY
15
A
MET
16
n
16
MET
16
A
CYS
17
n
17
CYS
17
A
CYS
18
n
18
CYS
18
A
LYS
19
n
19
LYS
19
A
THR
20
n
20
THR
20
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
5
A
N
CYS
5
A
O
GLY
15
A
O
GLY
15
1
A
ILE
3
-69.98
96.45
1
A
PHE
4
-50.34
106.07
1
A
CYS
9
-129.28
-56.35
1
A
HIS
10
-73.35
-137.96
1
A
CYS
18
-90.15
55.08
2
A
PHE
4
-45.18
93.14
2
A
CYS
9
-129.04
-55.45
2
A
HIS
10
-81.88
-137.17
2
A
CYS
18
-102.60
51.37
3
A
PHE
4
-43.96
91.61
3
A
CYS
9
-129.14
-54.72
3
A
HIS
10
-80.04
-136.88
4
A
PHE
4
-44.52
99.33
4
A
CYS
9
-129.37
-54.97
4
A
HIS
10
-75.81
-135.66
5
A
ILE
3
-68.92
96.64
5
A
PHE
4
-49.68
99.69
5
A
CYS
6
-90.39
59.85
5
A
CYS
9
-128.71
-55.87
5
A
HIS
10
-77.37
-132.30
5
A
CYS
18
-105.76
49.75
6
A
PHE
4
-44.26
93.24
6
A
CYS
9
-128.93
-52.78
6
A
HIS
10
-73.46
-142.01
6
A
CYS
18
-98.79
52.03
6
A
LYS
19
-110.67
56.87
7
A
PHE
4
-46.34
106.12
7
A
CYS
9
-129.46
-58.08
7
A
HIS
10
-75.80
-128.88
8
A
PHE
4
-50.27
102.79
8
A
CYS
6
-91.18
58.14
8
A
CYS
9
-129.21
-64.82
8
A
HIS
10
-84.07
-122.76
9
A
PHE
4
-50.89
98.99
9
A
CYS
9
-129.60
-57.13
9
A
HIS
10
-79.63
-130.45
9
A
LYS
19
-29.86
-45.09
10
A
PHE
4
-47.52
105.46
10
A
CYS
9
-128.64
-66.23
10
A
HIS
10
-120.84
-52.95
11
A
PHE
4
-50.54
104.89
11
A
CYS
9
-129.23
-56.63
11
A
HIS
10
-74.64
-137.15
11
A
LYS
19
-32.08
135.19
12
A
ILE
3
-66.85
97.39
12
A
PHE
4
-49.74
104.65
12
A
CYS
9
-128.96
-54.31
12
A
HIS
10
-75.26
-138.57
13
A
ILE
3
-61.56
98.52
13
A
PHE
4
-53.09
94.66
13
A
CYS
9
-129.05
-55.50
13
A
HIS
10
-74.87
-140.21
14
A
PHE
4
-47.78
105.18
14
A
CYS
8
-66.77
-73.95
14
A
HIS
10
-74.76
-128.71
15
A
PHE
4
-47.88
106.78
15
A
CYS
9
-128.70
-53.36
15
A
HIS
10
-73.15
-142.22
15
A
LYS
19
-49.88
153.02
16
A
ILE
3
-62.71
97.63
16
A
PHE
4
-50.76
104.95
16
A
CYS
8
-74.32
-75.12
16
A
HIS
10
-71.96
-137.11
17
A
PHE
4
-46.93
105.89
17
A
CYS
9
-129.22
-56.80
17
A
HIS
10
-74.98
-139.74
18
A
ILE
3
-67.52
96.96
18
A
PHE
4
-48.83
107.61
18
A
CYS
9
-128.84
-56.52
18
A
HIS
10
-73.27
-141.01
19
A
ILE
3
-62.96
97.73
19
A
PHE
4
-49.46
107.36
19
A
CYS
9
-128.91
-64.75
19
A
HIS
10
-80.61
-135.13
20
A
ILE
3
-62.67
97.77
20
A
PHE
4
-52.13
100.38
20
A
CYS
9
-129.47
-62.49
20
A
HIS
10
-79.43
-126.77
Solution Structure of Hepcidin-20
1
N
N
disulf
2.031
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
18
A
SG
CYS
18
1_555
disulf
2.030
A
CYS
5
A
SG
CYS
5
1_555
A
CYS
17
A
SG
CYS
17
1_555
disulf
2.033
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
14
A
SG
CYS
14
1_555
disulf
2.086
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
9
A
SG
CYS
9
1_555
ANTIMICROBIAL PROTEIN
strand-loop-strand, beta-sheet, hairpin loop, ANTIMICROBIAL PROTEIN
HEPC_HUMAN
UNP
1
65
P81172
ICIFCCGCCHRSKCGMCCKT
65
84
1M4E
1
20
P81172
A
1
1
20
2
anti-parallel
A
ILE
3
A
ILE
3
A
CYS
6
A
CYS
6
A
CYS
14
A
CYS
14
A
CYS
17
A
CYS
17